Catalyst Wire Dossier Catalyst Wire Dossier

Erbitux (cetuximab)

cetuximab · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Erbitux (cetuximab), covering 2009-12-04 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer [Phase 2]

See pricing